STAT6-IN-2
CAS No. 1355594-85-2
STAT6-IN-2( —— )
Catalog No. M37229 CAS No. 1355594-85-2
STAT6-IN-2 (Comp R-84) is a STAT6 inhibitor that effectively reduces the secretion of the chemokine eotaxin-3, which induces eosinophil infiltration. This compound is valuable for studying immune diseases .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 112 | In Stock |
|
| 5MG | 170 | In Stock |
|
| 10MG | 282 | In Stock |
|
| 25MG | 548 | In Stock |
|
| 50MG | 877 | In Stock |
|
| 100MG | 1377 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSTAT6-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionSTAT6-IN-2 (Comp R-84) is a STAT6 inhibitor that effectively reduces the secretion of the chemokine eotaxin-3, which induces eosinophil infiltration. This compound is valuable for studying immune diseases .
-
DescriptionSTAT6-IN-2 (Comp R-84) is an inhibitor of STAT6. STAT6-IN-2 inhibits the secretion of chemokine eliciting eosinophil infiltration eotaxin-3. STAT6-IN-2 can be used for immune disease research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorSTAT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1355594-85-2
-
Formula Weight469.58
-
Molecular FormulaC28H31N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (212.96 mM; Ultrasonic )
-
SMILESCN1C(C=2C=C(C(N[C@@H](C(C)C)C)=O)N=C(C(NCCC3=CC=CC=N3)=O)C2)=CC=4C1=CC=CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhou L, et.al. STAT6 phosphorylation inhibitors block eotaxin-3 secretion in bronchial epithelial cells. Bioorg Med Chem. 2012 Jan 15;20(2):750-8.?
molnova catalog
related products
-
Enzaplatovir
Enzaplatovir (BTA-585) is an orally available fusion inhibitor with antiviral activity for the study of respiratory syncytial virus infections and coronavirus disease (COVID-19) infections.
-
C188-9 (b)
A novel small-molecule STAT3 inhibitor with Ki of 12.4 nM; inhibits STAT3 binding to its pY-peptide ligand.
-
Totrombopag
Totrombopag (SB559448) is a candidate compound for action on RSV polymerase.
Cart
sales@molnova.com